Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012584 · ClinicalTrials.gov registry record · NA
Treatment of Youth With ADHD and Anxiety
A NA study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT00012584 is a NA study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 120 participants.
The verdict
NCT00012584, a NA study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of this NIMH-sponsored pilot study is to collect information on the efficacy and safety of drug treatments for children and adolescents who suffer from both ADHD and anxiety disorders. Specifically, the study will examine the benefits of the stimulant medication both alone and in combination with fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) that has antianxiety effects. Young people aged 6 to 17 diagnosed with these co-occurring disorders may be eligible to participate.
Interventions
- DRUG methylphenidate
- DRUG fluvoxamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2000-11 |
| Est. Completion | 2002-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00012584
The ClinicalTrials.gov registry entry for NCT00012584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which methylphenidate is the first listed.
NCT00012584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00012584 about?
NCT00012584 is a clinical study titled "Treatment of Youth With ADHD and Anxiety". The purpose of this NIMH-sponsored pilot study is to collect information on the efficacy and safety of drug treatments for children and adolescents who suffer from both ADHD and anxiety disorders. Specifically, the study will examine the benefits of the stimulant medication both alone and in combina...
What is the current status of trial NCT00012584?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2000-11. Estimated completion is 2002-05.
What interventions are being tested in trial NCT00012584?
The interventions under investigation include: methylphenidate (DRUG), fluvoxamine (DRUG).
Who is sponsoring clinical trial NCT00012584?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.